Maccario M, Grottoli S, Razzore P, Procopio M, Oleandri SE, Ciccarelli E, Camanni (5, 6 ). An increase in glucoseinduced insulin secretion in hyperprolactinemic patients has also been reported by some authors (7) (8) (9) (10) (11) but not by others (12) . Interestingly, recent data in animals and in men suggest that prolactin plays a major role in /3-cell trophism, as well as on insulin synthesis and secretion (13) (14) (15) (17, 18) . In man a synergistic effect of arginine and glucose upon insulin secretion has also been shown (19) (20) (21) , and combined administration of these two stimuli has already been studied in an attempt to probe /3-cell secretory capacity in diabetic patients (22) . On (Fig. 2) .
Growth hormone. (19, 20) . On the other hand, somatotrope responsiveness to ARG is preserved in hyperprolactinemia, while it is reduced in obesity.
An exaggerated insulin response to oral glucose load has already been reported both in physiological (pregnancy) and pathological (idiopathic and tumoral) hyperprolactinemia (7) (8) (9) (10) (11) 27) : it was found to be reversed by PRL normalization after pregnancy (9) or during treatment with dopaminergic agonists (8) . Insulin hyperresponsiveness to glucose load, however, was not confirmed by other authors (12) . In (12) showing that in hyperprolacti¬ nemia the insulin hyperresponsiveness is not detected by glucose load alone, but is clearly unmasked by ARG.
To explain the existence of insulin hypersécrétion in hyperprolactinemia, there are data in animals and in man showing that PRL has a stimulatory influence on insulin secretion (13, 14) . In fact, PRL exerts a trophic (13) (14) (15) . Interestingly, in the rat, the effect of PRL on insulin synthesis and secretion as well as on beta cell proliferation has been found to be considerably higher than GH (13, 28) .
Moreover, more recent data indicate that the effects of GH on beta cell trophism and secretion are mediated via lactotrope receptors (29) .
In the present study we found that glucose load in obese patients induced an increase in plasma glucose levels that was higher and long lasting than in controls and in hyperprolactinemic patients. Moreover (10, 30) .
As regards somatotrope secretion, we found that the ARG-induced GH response is preserved in hyperprolac¬ tinemia but is reduced in obesity. In obesity, the impairment of both spontaneous and stimulated GH secretion is well known (5, 6) . In order to explain this GH insufficiency, it has been hypothesized that hypothalamic and/or metabolic alteration could have a role (31) (32) (33) (34) (35) (16) . Reduced lactotrope responsiveness to stimulation has also been reported in obesity (38, 39) . In the present study we agree with these data by finding a trend toward low PRL responsiveness in obese patients.
In conclusion, the results of the present study reinforce the hypothesis that hyperprolactinemia is a condition of insulin hypersécrétion and underline the metabolic role of PRL in humans.
